- Home
- FTH vs APXT Comparison
FTH vs APXT Comparison
Compare FTH & APXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$21.84
N/A
Current Price
$10.17
Company Overview
Basic Information| Metric | FTH | APXT |
|---|---|---|
| Founded | 1999 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.8M | 467.0M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FTH | APXT |
|---|---|---|
| Price | $21.84 | $10.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $55.31 | N/A |
| AVG Volume (30 Days) | ★ 351.3K | 103.8K |
| Earning Date | 11-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.57 | $9.87 |
| 52 Week High | $42.14 | $10.19 |
Technical Indicators
Market Signals| Indicator | FTH | APXT |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 61.03 |
| Support Level | $16.57 | $10.12 |
| Resistance Level | $21.97 | $10.18 |
| Average True Range (ATR) | 2.02 | 0.01 |
| MACD | 0.65 | 0.00 |
| Stochastic Oscillator | 87.41 | 66.78 |
Price Performance
Historical Comparison FTH
APXT
About FTH Faeth Therapeutics Inc. Common Stock
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
About APXT Apex Treasury Corporation Class A Ordinary Share
Apex Treasury Corp is a blank check company established for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.